AACR News: XL-184 (Cabozantinib) goes 12-for-12 in colorectal cancer explants
April 8, 2013 · Comments Off
The novel c-MET and VEGFR2 inhibitor, XL-184 (Cabozantinib), resulted in a significant decrease in tumor growth in 12 out of 12 colorectal cancer (CRC) patient-derived explants, with 8 of the explants exhibiting stable disease. The results of this preclinical work are presented at the AACR Annual Meeting 2013.
“It’s now a part of our family history”
April 23, 2012 · Comments Off
Blindsided by multiple cancer diagnoses in one year, family and friends decide to do something...
In partnership with the American Society of Clinical Oncology including University of Colorado Cancer Center...
Tortoise and the Hare: New drug stops rushing cancer cells, slow and steady healthy cells unharmed
March 1, 2012 · Comments Off
3 Key Points Cancer cells rush through the steps of replication by depending on two...
Messersmith: We’re in the middle of a cancer revolution
June 7, 2011 · Comments Off
I take care of patients with gastrointestinal cancers in the clinic two days a week....
NIH grant funds search for colorectal cancer biomarkers
February 2, 2011 · Comments Off
University of Colorado Cancer Center researchers have received a $1.25 million grant to identify genetic...
The University of Colorado Cancer Center is enrolling patients in a clinical trial for a...
Colo. cancer patients win big as Gov. Ritter signs two patient access bills into law
May 17, 2010 · Comments Off
Cancer patients in Colorado scored a big win today as Colorado Gov. Bill Ritter signed...
Messersmith, UCCC gastrointestinal cancer program leader, talks about esophageal cancer
February 2, 2010 · Comments Off
Dr. Wells Messersmith, University of Colorado Cancer Center gastrointestinal cancer program leader and associate professor...
Bitter melon juice prevents pancreatic cancer in mouse models
February 2, 2010
NTRK1: a new oncogene and target in lung cancer
February 2, 2010
NEJM: Crizotinib Effective in Phase 1 Trial Against ROS1 Lung Cancer
September 30, 2014 · No comments
ALK amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer research colorado cancer stem cells Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant james degregori jennifer richer leukemia lung cancer lung cancer research melanoma microRNA ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
Another fantastic article by our guest blogger Celia Ruiz Tomlinson. fb.me/2HHwiDGD0
CU Cancer Center researcher looks into female sexual health after cancer treatment. “This is a subject that no... fb.me/6OkYVDAdD
Race for the Cure is tomorrow! We hope to see you there! fb.me/6BZ6FkEi0